Yixintang Pharmaceutical Group 一心堂
19 significant filings since 1 Jun 2026: 2 on share pledge, 8 on guarantee or financial assistance and 5 on share issue, and 2 other kinds. The latest, on 19 Sep 2026: 2026年中期权益分派实施的更正公告.
自 1 Jun 2026 起有 19 份重大公告：share pledge 2 份、guarantee or financial assistance 8 份、share issue 5 份，另有 2 类。最新一份（19 Sep 2026）：2026年中期权益分派实施的更正公告。
Price History 价格走势
2,881 trading days 个交易日 · High 最高 ¥42.53 · Low 最低 ¥7.31The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 29 Oct 2020 | 国元证券 | 常启辉 | Outperform 增持 | ▲ | Buy 买入 |
| 19 Aug 2020 | 国元证券 | 常启辉 | Buy 买入 | ▼ | Outperform 增持 |
| 18 Jul 2017 | 西南证券 | 朱国广 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 西南证券 | 杜向阳 | Unrated | 7 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 1 report. 每行为该券商近十二个月的最新研报；1 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。